ReWalk Robotics Ltd. 4
4 · ReWalk Robotics Ltd. · Filed Jun 28, 2017
Insider Transaction Report
Form 4
SCP Vitalife Partners II LP
10% Owner
Transactions
- Sale
Ordinary Shares, par value NIS 0.01 per share
2017-06-26$3.00/sh−27,759$83,277→ 1,055,133 total - Sale
Ordinary Shares, par value NIS 0.01 per share
2017-06-27$3.09/sh−37,459$115,864→ 1,017,674 total
Footnotes (3)
- [F1]Transaction made pursuant to a Rule 10b5-1 trading plan adopted December 15, 2016.
- [F2]The Ordinary Shares are directly held by SCP Vitalife Partners II, L.P. ("SCP Vitalife") and indirectly held by SCP Vitalife II Associates, L.P. ("SCP Vitalife Associates"), the sole general partner of SCP Vitalife, SCP Vitalife II, GP, Ltd. ("SCP Vitalife GP"), the sole general partner of SCP Vitalife Associates, and the individual directors of SCP Vitalife GP (SCP Vitalife Associates, SCP Vitalife GP and the individual directors of SCP Vitalife GP together, the "SCP Vitalife Indirect Reporting Persons"). The individual directors of SCP Vitalife GP are Jeffrey Dykan, Winston J. Churchill, Abraham Ludomirski and Wayne B. Weisman. The SCP Vitalife Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the SCP Vitalife Ordinary Shares in which the SCP Vitalife Indirect Reporting Persons have no pecuniary interest.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.0000 to $3.2000, inclusive. The reporting person undertakes to provide to ReWalk Robotics, Ltd. ("ReWalk"), any security holder of ReWalk, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.